Clinical trial
The Neurobiology of Depressive Illness
NCT00168493 · Baker Heart Research Institute, Other · Unknown status
Key facts
| NCT number | NCT00168493 |
|---|---|
| Title | The Neurobiology of Depressive Illness |
| Official title | The Neurobiology of Depressive Illness: Causes and Consequences of Altered Brain Monoaminergic Function |
| Lead sponsor | Baker Heart Research Institute, Other |
| Collaborators | National Health and Medical Research Council, Australia |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Major Depression |
| Intervention type | Drug |
| Interventions | antidepressants primarily selective serotonin reuptake inhibitors |
| Enrollment | 40 |
| Start date | Jun 1, 2000 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2009 |
| First posted | Sep 15, 2005 |
| Last update posted | May 20, 2008 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: